News & Events

Keep up to date with Isogenica’s latest news on collaborations, Press Releases, Events and VHH antibody resources.

Isogenica Lab


Latest News


Isogenica-PipeBio Collaboration Press Release

Isogenica announce deployment of the PipeBio Bioinformatic Cloud        Isogenica today announce that they are deploying PipeBio’s bioinformatic cloud to accelerate their drug...

Dr Bill Eldridge promoted to CSO

Isogenica announced today that Dr William (Bill) Eldridge has been promoted to Chief Scientific Officer. Since joining Isogenica as Senior Director of Antibody Alliances in January 2020, Dr Eldridge...


Catch up on Isogenica’s latest activities.


Isogenica is excited to announce its corporate sponsorship at PEGS  November 2-4th 2021Isogenica is delighted to announce its successful attendance at PEGS Europe 2021 as Corporate Sponsors, were...

FESTIVAL OF BIOLOGICS 2021: Silver Sponsors

Join Isogenica at Festival of Biologics  November 9-11th 2021, Basel. Isogenica is delighted to announce its attendance at Festival of Biologics 2021 as Silver Sponsors. Members of the Isogenica...


Isogenica attended ELRIG: Drug Discovery October 19-20th 2021Isogenica's Research Scientist, David Knight, attended ELRIG: Drug Discovery 2021 where he presented a poster on the latest Isogenica VHH...


Webinars are a great source for the latest activities at Isogenica. Hear all about the newest applications of VHH.

Nature Webinar

Register for Isogenica's upcoming webinar Join Isogenica for the upcoming webinar with Nature on 'VHH as building blocks for immune and tumour cell-targeting', presented by Isogenica's CSO Bill...


Due to their unique characteristics, VHH are promising candidates for a range of application areas including intracellular targeting and even across the Blood Brain Barrier (BBB). Discover all the benefits in using VHH in different applications.

VHH antibodies as biotherapeutics

Camelid heavy-chain only antibodies were discovered in the early 1990’s. Often referred to as VHH antibodies, they are a well characterized alternative to therapeutic IgG’s. Camelid heavy-chain only...

read more